カテゴリー： Market Monitor Global, 世界, 医療/バイオ

肺がん低侵襲治療の世界市場見通し2023年-2029年

◆英語タイトル：Minimally Invasive Treatment of Lung Cancer Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5303）

◆商品コード：MMG23JU5303
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：68
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Minimally Invasive Treatment of Lung Cancer Market 調査レポートは次の情報を含め、グローバルにおけるの肺がん低侵襲治療市場規模と予測を収録しています。・世界の肺がん低侵襲治療市場：売上、2018年-2023年、2024年-2029年
・世界の肺がん低侵襲治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の肺がん低侵襲治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肺腫瘍アブレーション」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

肺がん低侵襲治療のグローバル主要企業は、Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECHなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、肺がん低侵襲治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の肺がん低侵襲治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の肺がん低侵襲治療市場：タイプ別市場シェア、2022年
・肺腫瘍アブレーション、肺腫瘍塞栓術

世界の肺がん低侵襲治療市場：用途別、2018年-2023年、2024年-2029年
世界の肺がん低侵襲治療市場：用途別市場シェア、2022年
・病院、外来手術センター

世界の肺がん低侵襲治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の肺がん低侵襲治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における肺がん低侵襲治療のグローバル売上、2018年-2023年
・主要企業における肺がん低侵襲治療のグローバル売上シェア、2022年
・主要企業における肺がん低侵襲治療のグローバル販売量、2018年-2023年
・主要企業における肺がん低侵襲治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECH

*************************************************************

・調査・分析レポートの概要
肺がん低侵襲治療市場の定義
市場セグメント
世界の肺がん低侵襲治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の肺がん低侵襲治療市場規模
世界の肺がん低侵襲治療市場規模：2022年 VS 2029年
世界の肺がん低侵襲治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの肺がん低侵襲治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の肺がん低侵襲治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：肺腫瘍アブレーション、肺腫瘍塞栓術
肺がん低侵襲治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、外来手術センター
肺がん低侵襲治療の用途別グローバル売上・予測

・地域別市場分析
地域別肺がん低侵襲治療市場規模 2022年と2029年
地域別肺がん低侵襲治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECH
...

The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer. This report contains market size and forecasts of Minimally Invasive Treatment of Lung Cancer in global, including the following market information:
Global Minimally Invasive Treatment of Lung Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Lung Tumor Ablation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific and Smith and Nephew, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Minimally Invasive Treatment of Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Minimally Invasive Treatment of Lung Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Type, 2022 (%)
Lung Tumor Ablation
Lung Tumor Embolization
Global Minimally Invasive Treatment of Lung Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Global Minimally Invasive Treatment of Lung Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Minimally Invasive Treatment of Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Minimally Invasive Treatment of Lung Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Minimally Invasive Treatment of Lung Cancer, market overview.
Chapter 2: Global Minimally Invasive Treatment of Lung Cancer market size in revenue.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Minimally Invasive Treatment of Lung Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Minimally Invasive Treatment of Lung Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Minimally Invasive Treatment of Lung Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Minimally Invasive Treatment of Lung Cancer Overall Market Size
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2029
2.2 Global Minimally Invasive Treatment of Lung Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.2 Top Global Minimally Invasive Treatment of Lung Cancer Companies Ranked by Revenue
3.3 Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies
3.4 Top 3 and Top 5 Minimally Invasive Treatment of Lung Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.6.1 List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Minimally Invasive Treatment of Lung Cancer Market Size Markets, 2022 & 2029
4.1.2 Lung Tumor Ablation
4.1.3 Lung Tumor Embolization
4.2 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
4.2.1 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
4.2.2 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
4.2.3 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.2 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
5.2.1 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
5.2.2 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
5.2.3 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
6.2 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
6.2.1 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
6.2.2 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
6.2.3 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.3.2 US Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.3 Canada Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.4 Mexico Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.4.2 Germany Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.3 France Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.4 U.K. Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.5 Italy Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.6 Russia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.8 Benelux Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.5.2 China Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.3 Japan Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.4 South Korea Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.6 India Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.6.2 Brazil Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6.3 Argentina Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.7.2 Turkey Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.3 Israel Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.5 UAE Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
7 Minimally Invasive Treatment of Lung Cancer Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Olympus
7.2.1 Olympus Company Summary
7.2.2 Olympus Business Overview
7.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.2.4 Olympus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.2.5 Olympus Key News & Latest Developments
7.3 LungCare
7.3.1 LungCare Company Summary
7.3.2 LungCare Business Overview
7.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.3.4 LungCare Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.3.5 LungCare Key News & Latest Developments
7.4 Broncus
7.4.1 Broncus Company Summary
7.4.2 Broncus Business Overview
7.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.4.4 Broncus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.4.5 Broncus Key News & Latest Developments
7.5 Intuitive Surgica
7.5.1 Intuitive Surgica Company Summary
7.5.2 Intuitive Surgica Business Overview
7.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.5.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.5.5 Intuitive Surgica Key News & Latest Developments
7.6 Auris Health
7.6.1 Auris Health Company Summary
7.6.2 Auris Health Business Overview
7.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.6.4 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.6.5 Auris Health Key News & Latest Developments
7.7 Angiodynamics
7.7.1 Angiodynamics Company Summary
7.7.2 Angiodynamics Business Overview
7.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.7.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.7.5 Angiodynamics Key News & Latest Developments
7.8 Boston Scientific
7.8.1 Boston Scientific Company Summary
7.8.2 Boston Scientific Business Overview
7.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.8.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.8.5 Boston Scientific Key News & Latest Developments
7.9 Smith and Nephew
7.9.1 Smith and Nephew Company Summary
7.9.2 Smith and Nephew Business Overview
7.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.9.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.9.5 Smith and Nephew Key News & Latest Developments
7.10 VISON Medical
7.10.1 VISON Medical Company Summary
7.10.2 VISON Medical Business Overview
7.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.10.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.10.5 VISON Medical Key News & Latest Developments
7.11 Nanjing MICRO-TECH
7.11.1 Nanjing MICRO-TECH Company Summary
7.11.2 Nanjing MICRO-TECH Business Overview
7.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.11.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.11.5 Nanjing MICRO-TECH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Minimally Invasive Treatment of Lung Cancer Market Opportunities & Trends in Global Market
Table 2. Minimally Invasive Treatment of Lung Cancer Market Drivers in Global Market
Table 3. Minimally Invasive Treatment of Lung Cancer Market Restraints in Global Market
Table 4. Key Players of Minimally Invasive Treatment of Lung Cancer in Global Market
Table 5. Top Minimally Invasive Treatment of Lung Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Minimally Invasive Treatment of Lung Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
Table 9. List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Medtronic Company Summary
Table 31. Medtronic Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 32. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. Olympus Company Summary
Table 35. Olympus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 36. Olympus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Olympus Key News & Latest Developments
Table 38. LungCare Company Summary
Table 39. LungCare Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 40. LungCare Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. LungCare Key News & Latest Developments
Table 42. Broncus Company Summary
Table 43. Broncus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 44. Broncus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Broncus Key News & Latest Developments
Table 46. Intuitive Surgica Company Summary
Table 47. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 48. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Intuitive Surgica Key News & Latest Developments
Table 50. Auris Health Company Summary
Table 51. Auris Health Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 52. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Auris Health Key News & Latest Developments
Table 54. Angiodynamics Company Summary
Table 55. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 56. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Angiodynamics Key News & Latest Developments
Table 58. Boston Scientific Company Summary
Table 59. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 60. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Boston Scientific Key News & Latest Developments
Table 62. Smith and Nephew Company Summary
Table 63. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 64. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Smith and Nephew Key News & Latest Developments
Table 66. VISON Medical Company Summary
Table 67. VISON Medical Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 68. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. VISON Medical Key News & Latest Developments
Table 70. Nanjing MICRO-TECH Company Summary
Table 71. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 72. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Nanjing MICRO-TECH Key News & Latest Developments
List of Figures
Figure 1. Minimally Invasive Treatment of Lung Cancer Segment by Type in 2022
Figure 2. Minimally Invasive Treatment of Lung Cancer Segment by Application in 2022
Figure 3. Global Minimally Invasive Treatment of Lung Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2022
Figure 8. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 16. US Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 28. China Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Olympus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. LungCare Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Broncus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

肺がん低侵襲治療は、肺がんに対する治療法の一つであり、開胸手術などの従来の手術に比べて身体への侵襲を最小限に抑えることを目的としています。この治療法は、患者の回復を早め、合併症のリスクを減少させることが期待されています。以下に、低侵襲治療の概念、特徴、種類、用途、関連技術について詳細に述べます。

低侵襲治療の定義として、一般的には手術を行う際に、皮膚の切開を最小限に抑え、患者の身体に対するダメージを減少させる急速に発展している治療法のことを指します。肺がん患者において、低侵襲治療は、より小さな切開で完全に肺がんを除去したり、化学療法や放射線療法などの併用創手術による治療効果を高めたりすることを目指します。これにより、患者は術後の痛みが軽減され、早期の社会復帰が可能になるという利点があります。

低侵襲治療の特徴としては、まず第一に手術時の傷が小さく、身体への負担が少ないことが挙げられます。一般的な開胸手術の場合、大きな切開が必要であり、これには長い回復期間が必要ですが、低侵襲治療では小さな傷や穴を利用して手術が行われます。これに伴い、術後の痛みが軽減され、入院期間も短縮されることが期待されます。また、低侵襲治療によって、術後の合併症のリスクも低下することが多いです。

低侵襲治療の種類としては、主に内視鏡手術、ロボット支援手術、経皮的アプローチが挙げられます。内視鏡手術は、カメラと特殊な器具を使って胸腔内の手術を行う方法であり、これにより従来の開胸手術に比べて小さな切開で済みます。ロボット支援手術は、外科医がロボットを操作して手術を行うもので、より高精度で複雑な動作を行えるため、従来の方法よりも安全性が高くなります。また、経皮的アプローチは、皮膚を軽く穿刺することで腫瘍にアクセスし、治療を行う方法です。これにより、痛みや合併症をさらに軽減することが可能です。

低侵襲治療の用途は、肺がんの早期発見から進行したものまで幅広く対応し得ます。例えば、早期段階の肺がんに対しては、内視鏡手術や経皮的治療が行われることが一般的です。特に、腫瘍が小さなサイズのうちに発見された場合、低侵襲治療によって効果的に除去することが可能です。また、進行した肺がんに対しても、化学療法や放射線療法と組み合わせることで、全体的な治療効果を高めることができます。

関連技術としては、高度な医療機器や手術シミュレーション技術、画像診断技術が挙げられます。例えば、胸部CTやPETスキャンによる画像診断は、腫瘍の正確な位置や性質を把握するために欠かせません。また、手術計画を立てる際には、シミュレーション技術を用いて、手術の難易度や侵襲の程度を事前に評価することが可能となっています。これにより、外科医はより準備の整った状態で手術に臨むことができます。

さらに、低侵襲治療は従来の医療技術の進歩とともに発展してきました。例えば、内視鏡手術では、映像技術の進化により手術中の視認性が向上し、より精密な操作が可能になります。ロボット手術においても、ロボットの性能向上により、よりスムーズで緻密な手術が行えるようになりました。このように、関連技術との相乗効果によって、低侵襲治療は今後も進化を続けると考えられます。

患者への影響についても考慮すべき点があります。低侵襲治療により、患者は身体への負担が軽減されることが期待され、これにより心理的なストレスも軽減される可能性があります。また、術後の早期回復が実現されることにより、患者は早く日常生活に戻ることができ、治療に対する満足度も高まるでしょう。

全体として、肺がん低侵襲治療は、患者に配慮した新たな治療アプローチであり、今後の研究や技術の進展によってその可能性はさらに広がると考えられます。これにより、より多くの肺がん患者が恩恵を受け、最適な治療を受けられるようになることが期待されます。低侵襲治療は、今後ますます一般化することが予想され、肺がん治療の新たなスタンダードとなっていくでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺がん低侵襲治療の世界市場見通し2023年-2029年(Minimally Invasive Treatment of Lung Cancer Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

肺がん低侵襲治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp